Seltene Erkrankungen des Larynx, der Trachea und der Schilddrüse

Zusammenfassung

Der Übersichtsartikel beinhaltet eine Zusammenstellung seltener Erkrankungen von Larynx, Trachea und Schilddrüse. Im Speziellen werden angeborene Fehlbildungen, seltene Formen der entzündlichen Larynxerkrankungen, gutartige und bösartige epitheliale sowie nicht-epitheliale Tumoren, laryngeale und tracheale Manifestationen von Allgemeinerkrankungen und schließlich seltene Erkrankungen der Schilddrüse besprochen. Die einzelnen Kapitel beinhalten eine Übersicht über die Datenlage in der Literatur, das jeweilige klinische Erscheinungsbild, wichtige Stichpunkte zur Diagnostik und zur Therapie und eine abschließende Stellungnahme zur Prognose der Erkrankung. Des Weiteren finden sich Hinweise zu Studienregistern und Selbsthilfegruppen.

Schlüsselwörter

seltene Erkrankung - Larynx - Trachea - Schilddrüse

Publication History

Article published online:
30 April 2021

• Literatur

• 1 Holinger LD. Etiology of Stridor in the Neonate, Infant and Child. Ann Oto Rhinol Laryn 1980; 89: 397-400
• 2 Friedman EM, Vastola AP, Mcgill TJI. et al. Chronic Pediatric Stridor – Etiology and Outcome. Laryngoscope 1990; 100: 277-280
• 3 Zoumalan R, Maddalozzo J, Holinger LD. Etiology of stridor in infants. Ann Oto Rhinol Laryn 2007; 116: 329-334
• 4 Hoff SR, Schroeder JW, Rastatter JC. et al. Supraglottoplasty outcomes in relation to age and comorbid conditions. Int J Pediatr Otorhi 2010; 74: 245-249
• 5 Krashin E, Ben-Ari J, Springer C. et al. Synchronous airway lesions in laryngomalacia. Int J Pediatr Otorhi 2008; 72: 501-507
• 6 Schroeder JW, Bhandarkar ND, Holinger LD. Synchronous Airway Lesions and Outcomes in Infants With Severe Laryngomalacia Requiring Supraglottoplasty. Arch Otolaryngol 2009; 135: 647-651
• 7 Yuen HW, Tan HKK, Balakrishnan A. Synchronous airway lesions and associated anomalies in children with laryngomalacia evaluated with rigid endoscopy. Int J Pediatr Otorhi 2006; 70: 1779-1784
• 8 Olney DR, Greinwald JH, Smith RJH. et al. Laryngomalacia and its treatment. Laryngoscope 1999; 109: 1770-1775
• 9 Koitschev A, Sittel C. Laryngomalacia. When does surgery make sense?. HNO 2012; 60: 573-580
• 10 Sittel C. Pathologies of the larynx and trachea in childhood. Laryngorhinootologie 2014; 93: S70-S83
• 11 Werner JA, Lippert BM, Dunne AA. et al. Epiglottopexy for the treatment of severe laryngomalacia. Eur Arch Otorhinolaryngol 2002; 259: 459-464
• 12 Denoyelle F, Mondain M, Gresillon N. et al. Failures and complications of supraglottoplasty in children. Arch Otolaryngol Head Neck Surg 2003; 129: 1077-1080 discussion 1080
• 13 Toynton SC, Saunders MW, Bailey CM. Aryepiglottoplasty for laryngomalacia: 100 consecutive cases. J Laryngol Otol 2001; 115: 35-38
• 14 Sittel C, Monnier P, Peretti G. et al. Prognostic value of the ELS grading system for assessment of laryngotracheal stenosis in children. HNO 2020; 68: 407-413
• 15 Miyamoto RC, Parikh SR, Gellad W. et al. Bilateral congenital vocal cord paralysis: a 16-year institutional review. Otolaryngol Head Neck Surg 2005; 133: 241-245
• 16 Murty GE, Shinkwin C, Gibbin KP. Bilateral Vocal Fold Paralysis in Infants – Tracheostomy or Not. Journal of Laryngology and Otology 1994; 108: 329-331
• 17 Cohen SR, Geller KA, Birns JW. et al. Laryngeal paralysis in children: a long-term retrospective study. Ann Otol Rhinol Laryngol 1982; 91: 417-424
• 18 de Gaudemar I, Roudaire M, Francois M. et al. Outcome of laryngeal paralysis in neonates: a long term retrospective study of 113 cases. Int J Pediatr Otorhinolaryngol 1996; 34: 101-110
• 19 Daya H, Hosni A, Bejar-Solar I. et al. Pediatric vocal fold paralysis: a long-term retrospective study. Arch Otolaryngol Head Neck Surg 2000; 126: 21-25
• 20 Gentile RD, Miller RH, Woodson GE. Vocal cord paralysis in children 1 year of age and younger. Ann Otol Rhinol Laryngol 1986; 95: 622-625
• 21 Emery PJ, Fearon B. Vocal cord palsy in pediatric practice: a review of 71 cases. Int J Pediatr Otorhinolaryngol 1984; 8: 147-154
• 22 Zbar RI, Smith RJ. Vocal fold paralysis in infants twelve months of age and younger. Otolaryngol Head Neck Surg 1996; 114: 18-21
• 23 Berkowitz RG. Natural history of tracheostomy-dependent idiopathic congenital bilateral vocal fold paralysis. Otolaryngol Head Neck Surg 2007; 136: 649-652
• 24 Ruf K, Hackenberg S, Kraus F. et al. Carbon Dioxide Laser Cordotomy as Possible Alternative for Tracheotomy in a Neonate with Idiopathic Bilateral Vocal Fold Paralysis. Klin Padiatr 2016; 228: 213-215
• 25 Richter C. Dissertatio médico de infanticide inartis obstetriciae: Thesis for Doctor of Medicine. Leipzig; 1792
• 26 Roth B, Rose KG, Benzbohm G. et al. Laryngo-Tracheo-Esophageal Cleft – Clinical-Features, Diagnosis and Therapy. Eur J Pediatr 1983; 140: 41-46
• 27 Delahunty JE, Cherry J. Congenital Larygeal Cleft. Ann Oto Rhinol Laryn 1969; 78: 96-+
• 28 Watters K, Russell J. Diagnosis and management of type 1 laryngeal cleft. Int J Pediatr Otorhinolaryngol 2003; 67: 591-596
• 29 Rahbar R, Rouillon I, Roger G. et al. The presentation and management of laryngeal cleft: a 10-year experience. Arch Otolaryngol Head Neck Surg 2006; 132: 1335-1341
• 30 Rahbar R, Chen JL, Rosen RL. et al. Endoscopic repair of laryngeal cleft type I and type II: when and why?. Laryngoscope 2009; 119: 1797-1802
• 31 Benjamin B, Inglis A. Minor congenital laryngeal clefts: diagnosis and classification. Ann Otol Rhinol Laryngol 1989; 98: 417-420
• 32 Johnston DR, Watters K, Ferrari LR. et al. Laryngeal cleft: evaluation and management. Int J Pediatr Otorhinolaryngol 2014; 78: 905-911
• 33 Chien W, Ashland J, Haver K. et al. Type 1 laryngeal cleft: establishing a functional diagnostic and management algorithm. Int J Pediatr Otorhinolaryngol 2006; 70: 2073-2079
• 34 Sandu K, Monnier P. Endoscopic laryngotracheal cleft repair without tracheotomy or intubation. Laryngoscope 2006; 116: 630-634
• 35 Garabedian EN, Pezzettigotta S, Leboulanger N. et al. Endoscopic surgical treatment of laryngotracheal clefts: indications and limitations. Arch Otolaryngol Head Neck Surg 2010; 136: 70-74
• 36 Parsons DS, Stivers FE, Giovanetto DR. et al. Type I posterior laryngeal clefts. Laryngoscope 1998; 108: 403-410
• 37 van der Doef HP, Yntema JB, van den Hoogen FJ. et al. Clinical aspects of type 1 posterior laryngeal clefts: literature review and a report of 31 patients. Laryngoscope 2007; 117: 859-863
• 38 Kawaguchi AL, Donahoe PK, Ryan DP. Management and long-term follow-up of patients with types III and IV laryngotracheoesophageal clefts. J Pediatr Surg 2005; 40: 158-164. discussion 164–155
• 39 Ryan DP, Muehrcke DD, Doody DP. et al. Laryngotracheoesophageal cleft (type IV): management and repair of lesions beyond the carina. J Pediatr Surg 1991; 26: 962-969. discussion 969–970
• 40 Mathur NN, Peek GJ, Bailey CM. et al. Strategies for managing Type IV laryngotracheoesophageal clefts at Great Ormond Street Hospital for Children. Int J Pediatr Otorhinolaryngol 2006; 70: 1901-1910
• 41 Geller K, Kim Y, Koempel J. et al. Surgical management of type III and IV laryngotracheoesophageal clefts: the three-layered approach. Int J Pediatr Otorhinolaryngol 2010; 74: 652-657
• 42 Crisera CA, Grau JB, Maldonado TS. et al. Defective epithelial-mesenchymal interactions dictate the organogenesis of tracheoesophageal fistula. Pediatr Surg Int 2000; 16: 256-261
• 43 Crisera CA, Connelly PR, Marmureanu AR. et al. Esophageal atresia with tracheoesophageal fistula: suggested mechanism in faulty organogenesis. J Pediatr Surg 1999; 34: 204-208
• 44 Billmyre KK, Hutson M, Klingensmith J. One shall become two: Separation of the esophagus and trachea from the common foregut tube. Dev Dyn 2015; 244: 277-288
• 45 Cassina M, Ruol M, Pertile R. et al. Prevalence, characteristics, and survival of children with esophageal atresia: A 32-year population-based study including 1,417,724 consecutive newborns. Birth Defects Res A Clin Mol Teratol 2016; 106: 542-548
• 46 Muensterer OJ, Berdon WE. From Vogt to Haight and Holt to now: the history of esophageal atresia over the last century. Pediatr Radiol 2015; 45: 1230-1235
• 47 Parolini F, Morandi A, Macchini F. et al. Esophageal atresia with proximal tracheoesophageal fistula: A missed diagnosis. Journal of Pediatric Surgery 2013; 48: E13-E17
• 48 Pretorius DH, Drose JA, Dennis MA. et al. Tracheoesophageal fistula in utero. Twenty-two cases. J Ultrasound Med 1987; 6: 509-513
• 49 Karnak I, Senocak ME, Hicsonmez A. et al. The diagnosis and treatment of H-type tracheoesophageal fistula. J Pediatr Surg 1997; 32: 1670-1674
• 50 Salik I, Paul M. Tracheoesophageal Fistula. In StatPearls. Treasure Island (FL): 2020
• 51 Sparey C, Jawaheer G, Barrett AM. et al. Esophageal atresia in the Northern Region Congenital Anomaly Survey, 1985-1997: prenatal diagnosis and outcome. Am J Obstet Gynecol 2000; 182: 427-431
• 52 Rothenberg SS. Thoracoscopic repair of esophageal atresia and tracheo-esophageal fistula. Semin Pediatr Surg 2005; 14: 2-7
• 53 Rothenberg SS. Thoracoscopic repair of esophageal atresia and tracheo-esophageal fistula in neonates: evolution of a technique. J Laparoendosc Adv Surg Tech A 2012; 22: 195-199
• 54 Holinger PH, Brown WT. Congenital webs, cysts, laryngoceles and other anomalies of the larynx. Ann Otol Rhinol Laryngol 1967; 76: 744-752
• 55 Nicollas R, Triglia JM. The anterior laryngeal webs. Otolaryngol Clin North Am 2008; 41: 877-888 viii
• 56 Miyamoto RC, Cotton RT, Rope AF. et al. Association of anterior glottic webs with velocardiofacial syndrome (chromosome 22q11.2 deletion). Otolaryngol Head Neck Surg 2004; 130: 415-417
• 57 Lim FY, Crombleholme TM, Hedrick HL. et al. Congenital high airway obstruction syndrome: natural history and management. J Pediatr Surg 2003; 38: 940-945
• 58 Lawlor CM, Dombrowski ND, Nuss RC. et al. Laryngeal Web in the Pediatric Population: Evaluation and Management. Otolaryngol Head Neck Surg 2020; 162: 234-240
• 59 Rodriguez H, Cuestas G, Zanetta A. Dysphonia in children due to congenital laryngeal web. Case series. Arch Argent Pediatr 2013; 111: E82-E85
• 60 Wyatt ME, Hartley BEJ. Laryngotracheal reconstruction in congenital laryngeal webs and atresias. Otolaryng Head Neck 2005; 132: 232-238
• 61 de Trey LA, Lambercy K, Monnier P. et al. Management of severe congenital laryngeal webs – a 12 year review. Int J Pediatr Otorhinolaryngol 2016; 86: 82-86
• 62 Schummer W, Schummer C, Klemm P. et al. Tracheal agenesis. A rare cause of respiratory insufficiency in neonates. Anaesthesist 2006; 55: 1259-1265
• 63 Floyd J, Campbell DC, Dominy DE. Agenesis of the trachea. Am Rev Respir Dis 1962; 86: 557-560
• 64 Varela P, Torre M, Schweiger C. et al. Congenital tracheal malformations. Pediatr Surg Int 2018; 34: 701-713
• 65 Smith MM, Huang A, Labbe M. et al. Clinical presentation and airway management of tracheal atresia: A systematic review. Int J Pediatr Otorhinolaryngol 2017; 101: 57-64
• 66 Kalache KD, Chaoui R, Bollmann R. Doppler assessment of tracheal and nasal fluid flow during fetal breathing movements: preliminary observations. Ultrasound Obstet Gynecol 1997; 9: 257-261
• 67 Seifert GJNuN. Rachen und Tonsillen, Ohr, Larynx. Berlin, Heidelberg, New York: HNO-Pathologie; 1999. DOI 67-68
• 68 Lahav G, Lahav Y, Ciobotaro P. et al. Laryngeal Syphilis A Case Report. Arch Otolaryngol 2011; 137: 294-297
• 69 Singh B, Balwally AN, Nash M. et al. Laryngeal tuberculosis in HIV-infected patients: A difficult diagnosis. Laryngoscope 1996; 106: 1238-1240
• 70 Wang CC, Lin CC, Wang CP. et al. Laryngeal tuberculosis: A review of 26 cases. Otolaryng Head Neck 2007; 137: 582-588
• 71 Lim JY, Kim KM, Choi EC. et al. Current clinical propensity of laryngeal tuberculosis: review of 60 cases. Eur Arch Oto-Rhino-L 2006; 263: 838-842
• 72 Agarwal R, Gupta L, Singh M. et al. Primary Laryngeal Tuberculosis: A Series of 15 Cases. Head Neck Pathol 2019; 13: 339-343
• 73 Bailey CM, Windletaylor PC. Tuberculous Laryngitis – a Series of 37 Patients. Laryngoscope 1981; 91: 93-100
• 74 Swain SK, Behera IC, Sahu MC. Primary Laryngeal Tuberculosis: Our Experiences at a Tertiary Care Teaching Hospital in Eastern India. J Voice 2019; 33: 812, e819-812, e814
• 75 Wang CC, Lin CC, Wang CP. et al. Laryngeal tuberculosis: a review of 26 cases. Otolaryngol Head Neck Surg 2007; 137: 582-588
• 76 Soni NK. Leprosy of the larynx. J Laryngol Otol 1992; 106: 518-520
• 77 Moraes BT, Filho Fde S, Neto JC. et al. Laryngeal leishmaniasis. Int Arch Otorhinolaryngol 2012; 16: 523-526
• 78 Grant A, Spraggs PD, Grant HR. et al. Laryngeal leishmaniasis. J Laryngol Otol 1994; 108: 1086-1088
• 79 Guerra JAD, Prestes SR, Silveira H. et al. Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon. Plos Neglect Trop D 2011; 5
• 80 Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199
• 81 Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope 2008; 118: 1236-1247
• 82 Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. APMIS 2010; 118: 450-454
• 83 Rabah R, Lancaster WD, Thomas R. et al. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 2001; 4: 68-72
• 84 Rodier C, Lapointe A, Coutlee F. et al. Juvenile respiratory papillomatosis: risk factors for severity. J Med Virol 2013; 85: 1447-1458
• 85 Silver RD, Rimell FL, Adams GL. et al. Diagnosis and management of pulmonary metastasis from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 2003; 129: 622-629
• 86 Derkay CS, Hester RP, Burke B. et al. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2004; 68: 1493-1498
• 87 Ivancic R, Iqbal H, deSilva B. et al. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol 2018; 3: 22-34
• 88 Langer C, Wittekindt C, Wolf G. Laryngeal Recurrent Respiratory Papillomatosis: Current Aspects on Diagnosis and Therapy. Laryngorhinootologie 2019; 98: 577-587
• 89 Dubey SP, Banerjee S, Ghosh LM. et al. Benign pleomorphic adenoma of the larynx: report of a case and review and analysis of 20 additional cases in the literature. Ear Nose Throat J 1997; 76: 548-550 552, 554-547
• 90 Kovarik J, Milne D, Robinson M. et al. Primary carcinoma ex-pleomorphic adenoma of anterior commissure of the larynx. Oral Oncol 2018; 84: 131-133
• 91 Milford CA, Mugliston TA, O’Flynn P. et al. Carcinoma arising in a pleomorphic adenoma of the epiglottis. J Laryngol Otol 1989; 103: 324-327
• 92 Ito A, Sone M, Kitamura Y. et al. A case of pleomorphic adenoma of the epiglottis. Bilateral vocal-cord paralysis after YAG laser surgery. Auris Nasus Larynx 1997; 24: 303-307
• 93 Pardal Refoyo JL, Gonzalez del Rey MC, Ursua Sarmiento I. et al. Subglottic pleomorphic adenoma. An Otorrinolaringol Ibero Am 2001; 28: 129-137
• 94 Sim DW, Oh IJ, Kim KS. et al. Pleomorphic adenoma of the trachea. J Bronchology Interv Pulmonol 2014; 21: 230-233
• 95 Motahari SJ, Khavarinejad F, Salimi S. et al. Pleomorphic Adenoma of the Larynx: A Case Report. Iran J Otorhinolaryngol 2016; 28: 73-77
• 96 Argat M, Born IA, Maier H. et al. Pleomorphic adenoma of the larynx. Eur Arch Otorhinolaryngol 1994; 251: 304-306
• 97 Altunpulluk MD, Karabulut MH, Kir G. et al. Pleomorphic adenoma of the larynx. North Clin Istanb 2016; 3: 67-70
• 98 Suttner HJ, Stoss H, Iro H. Pleomorphic adenoma of the epiglottis. Case report and review of the literature. HNO 1992; 40: 453-455
• 99 Ozlugedik S, Tuncel U, Han U. et al. Laryngeal chondroma: a rare neck tumor in pediatric age. Int J Pediatr Otorhi 2004; 68: 1551-1555
• 100 Gokdogan O, Koybasioglu A, Ileri F. Laryngeal Chondroma: An Unusual Complication Endotracheal Entubation. Journal of Craniofacial Surgery 2016; 27: 1007-1009
• 101 Franco RA, Singh B, Har-El G. Laryngeal chondroma. Journal of Voice 2002; 16: 92-95
• 102 Tastekin E, Altaner S, Uzun C. et al. Laryngeal chondroma: a rare diagnosis in this localization. Case Rep Pathol 2011; 2011: 852396
• 103 Lai YT, Petty BE, Huang W. et al. Bilateral Vocal Fold Chondromas. Journal of Voice 2013; 27: 255-257
• 104 Yang SW, Lin CY. A peculiar site of chondroma: The epiglottis. Acta Oto-Laryngol 2005; 125: 906-909
• 105 Ozcan I, Ozcan KM, Selcuk A. et al. Hyoid chondroma presenting as an external neck mass. Journal of Craniofacial Surgery 2007; 18: 1184-1187
• 106 Gundlach P, Radke C, Waldschmidt J. Congenital laryngeal chondroma: an unusual cause of congenital stridor. Z Kinderchir 1990; 45: 182-184
• 107 Gulden JW, Straehler-Pohl HJ. Chondroma of the larynx--case report and differential diagnosis in CT. Bildgebung 1990; 57: 90-92
• 108 Tan Z, Yao M, Liu T. et al. Chondroma of laryngeal cartilage mimicking thyroid tumor: A case report. Medicine (Baltimore) 2019; 98: e15005
• 109 Baatenburg de Jong RJ, van Lent S, Hogendoorn PC. Chondroma and chondrosarcoma of the larynx. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 98-105
• 110 Chiu LD, Rasgon BM. Laryngeal chondroma: a benign process with long-term clinical implications. Ear Nose Throat J 1996; 75: 540-542 544-549
• 111 Verhulst J, Gal M, Carles D. et al. Chondroma and chondrosarcoma of the larynx: apropos of 4 cases. Rev Laryngol Otol Rhinol (Bord) 1996; 117: 183-188
• 112 Azandaryani AR, Eftekharian M, Taghipour M. Large Laryngeal Lipoma with Extra Laryngeal Component Mimics Mixed Form Laryngocele: A Case Report. Adv J Emerg Med 2019; 3: e45
• 113 Khorsandi Ashtiani MT, Yazdani N, Saeedi M. et al. Large lipoma of the larynx: a case report. Acta Med Iran 2010; 48: 353-356
• 114 Okromelidze L, Middlebrooks EH, Bhatt AA. Lipoma of the Larynx and Other Differential Diagnoses. J Clin Imaging Sci 2019; 9: 51
• 115 Costa NR, Duarte D, Viana M. Lipoma of the pre-epiglottic space: A common pathology in an uncommon place. Acta Otorrinolaringol Esp 2018; 69: 181-182
• 116 Durr ML, Agrawal N, Saunders JR. et al. Laryngeal lipoma associated with diffuse lipomatosis: case report and literature review. Ear Nose Throat J 2010; 89: 34-37
• 117 Burkes JN, Campos L, Williams FC. et al. Laryngeal Spindle Cell/Pleomorphic Lipoma: A Case Report. An In-Depth Review of the Adipocytic Tumors. J Oral Maxillofac Surg 2019; 77: 1401-1410
• 118 Wolf-Magele A, Schnabl J, Url C. et al. Acute dyspnea caused by a giant spindle cell lipoma of the larynx. Wien Klin Wochenschr 2016; 128: 146-149
• 119 Kodiyan J, Rudman JR, Rosow DE. et al. Lipoma and liposarcoma of the larynx: case reports and literature review. Am J Otolaryngol 2015; 36: 611-615
• 120 D’Antonio A, Mottola G, Caleo A. et al. Spindle cell lipoma of the larynx. Ear Nose Throat J 2013; 92: E9
• 121 Nonaka S, Enomoto K, Kawabori S. et al. Spindle cell lipoma within the larynx: a case report with correlated light and electron microscopy. ORL J Otorhinolaryngol Relat Spec 1993; 55: 147-149
• 122 Charpentier A, Thiesler T, Bartmann D. et al. [Slowly progressive dysphonia]. HNO 2019; 67: 952-954
• 123 De Vincentiis M, Greco A, Mascelli A. et al. Lipoma of the larynx: a case report. Acta Otorhinolaryngol Ital 2010; 30: 58-63
• 124 Sharma SJ, Kreisel M, Kroll T. et al. Extracardiac juvenile rhabdomyoma of the larynx: a rare pathological finding. Eur Arch Otorhinolaryngol 2013; 270: 773-776
• 125 Altissimi G, Ralli M, Sementilli G. et al. Adult-Type Rhabdomyoma of the Larynx: Clinicopathologic Study of an Uncommon Tumor in a Rare Location. Case Rep Otolaryngol 2017; 2017: 7186768
• 126 Balakumar R, Farr MRB, Fernando M. et al. Adult-Type Rhabdomyoma of the Larynx in Birt-Hogg-Dube Syndrome: Evidence for a Real Association. Head Neck Pathol 2019; 13: 507-511
• 127 Elawabdeh N, Sobol S, Blount AC. et al. Unusual presentation of extracardiac fetal rhabdomyoma of the larynx in a pediatric patient with tuberous sclerosis. Fetal Pediatr Pathol 2013; 31: 43-47
• 128 Johansen EC, Illum P. Rhabdomyoma of the larynx: a review of the literature with a summary of previously described cases of rhabdomyoma of the larynx and a report of a new case. J Laryngol Otol 1995; 109: 147-153
• 129 Hansen T, Katenkamp D. Rhabdomyoma of the head and neck: morphology and differential diagnosis. Virchows Arch 2005; 447: 849-854
• 130 Hamper K, Renninghoff J, Schafer H. Rhabdomyoma of the larynx recurring after 12 years: immunocytochemistry and differential diagnosis. Arch Otorhinolaryngol 1989; 246: 222-226
• 131 Sankar G, Rajaraman V, Ganesh RN. et al. Multiple Cutaneous Metastases on (99m)TC-HYNIC-TOC Scan in a Rare Case of Malignant Laryngeal Paraganglioma. Indian J Nucl Med 2018; 33: 348-350
• 132 Rubin AD, Cheng SS, Bradford CR. Laryngeal paraganglioma in a patient with multiple head and neck paragangliomas. Otolaryngol Head Neck Surg 2005; 132: 520-522
• 133 Williams MD. Paragangliomas of the Head and Neck: An Overview from Diagnosis to Genetics. Head Neck Pathol 2017; 11: 278-287
• 134 Piccini V, Rapizzi E, Bacca A. et al. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr Relat Cancer 2012; 19: 149-155
• 135 Schiavi F, Boedeker CC, Bausch B. et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 2005; 294: 2057-2063
• 136 Naik SM, Shenoy AM, Chavan P. et al. Laryngeal paraganglioma: a rare clinical entity managed by supraselective embolization and lateral pharygotomy. Indian J Otolaryngol Head Neck Surg 2013; 65: 95-104
• 137 Sesterhenn AM, Folz BJ, Lippert BM. et al. Laser surgical treatment of laryngeal paraganglioma. J Laryngol Otol 2003; 117: 641-646
• 138 Smolarz JR, Hanna EY, Williams MD. et al. Paraganglioma of the endolarynx: a rare tumor in an uncommon location. Head Neck Oncol 2010; 2: 2
• 139 Papacharalampous GX, Chrysovergis AI, Tsiambas E. et al. Laryngeal paragangliomas – controversies in diagnosis and management. J BUON 2009; 14: 405-409
• 140 Pellitteri PK, Rinaldo A, Myssiorek D. et al. Paragangliomas of the head and neck. Oral Oncol 2004; 40: 563-575
• 141 Rognone E, Rossi A, Conte M. et al. Laryngeal schwannoma in an 8-year-old boy with inspiratory dyspnea. Head Neck 2007; 29: 972-975
• 142 Wong BLK, Bathala S, Grant D. Laryngeal schwannoma: a systematic review. Eur Arch Otorhinolaryngol 2017; 274: 25-34
• 143 Romak JJ, Neel HB, Ekbom DC. Laryngeal Schwannoma: A Case Presentation and Review of the Mayo Clinic Experience. J Voice 2017; 31: 129 e115-129 e118
• 144 Ebmeyer J, Reineke U, Gehl HB. et al. Schwannoma of the larynx. Head Neck Oncol 2009; 1: 24
• 145 Ayad JB, Nekro C, Rokhssi S. et al. An unusual cause of high dysphagia: schwannoma of the preepiglottic space. Pan Afr Med J 2017; 28: 295
• 146 Tulli M, Bondi S, Bussi M. Voluminous laryngeal schwannoma excision with a mini-invasive external approach: a case report. Acta Otorhinolaryngol Ital 2017; 37: 242-244
• 147 Millas T, Granell J, Garrido L. et al. Transoral robotic approach for laryngeal schwannoma. Head Neck 2015; 37: E70-E73
• 148 Liu J, Wong CF, Lim F. et al. Glottic neurofibroma in an elderly patient: a case report. J Voice 2013; 27: 644-646
• 149 Dave SP, Farooq U, Civantos FJ. Management of advanced laryngeal and hypopharyngeal plexiform neurofibroma in adults. Am J Otolaryngol 2008; 29: 279-283
• 150 Mobashir MK, Mohamed AE, El-Anwar MW. et al. Massive Plexiform Neurofibroma of the Neck and Larynx. Int Arch Otorhinolaryngol 2015; 19: 349-353
• 151 Gstottner M, Galvan O, Gschwendtner A. et al. Solitary subglottic neurofibroma: a report of an unusual manifestation. Eur Arch Otorhinolaryngol 2005; 262: 705-707
• 152 Nakahira M, Nakatani H, Sawada S. et al. Neurofibroma of the larynx in neurofibromatosis: preoperative computed tomography and magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 2001; 127: 325-328
• 153 Friedrich RE, Korf B, Funsterer C. et al. Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images. Anticancer Res 2003; 23: 949-952
• 154 Chinn SB, Collar RM, McHugh JB. et al. Pediatric laryngeal neurofibroma: case report and review of the literature. Int J Pediatr Otorhinolaryngol 2014; 78: 142-147
• 155 Rahbar R, Litrovnik BG, Vargas SO. et al. The biology and management of laryngeal neurofibroma. Arch Otolaryngol 2004; 130: 1400-1406
• 156 Nolte E, Kleinsasser O. Granular-Cell Tumors of the Larynx. Hno 1982; 30: 333-339
• 157 Gonik NJ, Zeltsman D, Smith LP. Complicated pediatric subglottic granular cell tumor with extensive intraluminal and extraluminal invasion. Int J Pediatr Otorhi 2014; 78: 1563-1565
• 158 Valldeperes A, Thomas-Arrizabalaga I, Alvarez-Ceballos L. et al. Granular Cell Tumors of the Larynx: A Clinicopathologic Study of Five Patients. J Voice. 2019
• 159 Reiter R, Ruess J, Brosch S. et al. Refractory Therapy Hoarseness in Granular Cell Tumor of the Vocal Cord. Laryngo Rhino Otol 2016; 95: 125-126
• 160 McIntyre CJ, Allen JL, Powell H. et al. Novel surgical management of a laryngeal granular cell tumour. BMJ Case Rep 2015; 2015
• 161 Sproat R, Wong G, Rubin J. Granular Cell Tumour of the Larynx. Head Neck Pathol 2016; 10: 538-540
• 162 Park JH, Do NY, Cho SI. et al. Granular cell tumor on larynx. Clin Exp Otorhinolaryngol 2010; 3: 52-55
• 163 Gonik NJ, Zeltsman D, Smith LP. Complicated pediatric subglottic granular cell tumor with extensive intraluminal and extraluminal invasion. Int J Pediatr Otorhinolaryngol 2014; 78: 1563-1565
• 164 Conley SF, Milbrath MM, Beste DJ. Pediatric Laryngeal Granular-Cell Tumor. J Otolaryngol 1992; 21: 450-453
• 165 Ting M, Roseby R, McAdam C. Subglottic infantile haemangioma: A rare but important consideration in young infants presenting with stridor. J Paediatr Child Health 2016; 52: 1111-1113
• 166 Heyduck A, Pickhard A, Brosch S. et al. [Subglottic pathologies]. Laryngorhinootologie 2019; 98: 461-472
• 167 Darrow DH. Management of Infantile Hemangiomas of the Airway. Otolaryngol Clin North Am 2018; 51: 133-146
• 168 Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000; 37: 517-584
• 169 Schwartz T, Faria J, Pawar S. et al. Efficacy and rebound rates in propranolol-treated subglottic hemangioma: A literature review. Laryngoscope 2017; 127: 2665-2672
• 170 Rahbar R, Nicollas R, Roger G. et al. The biology and management of subglottic hemangioma: Past, present, future. Laryngoscope 2004; 114: 1880-1891
• 171 Nocini R, Molteni G, Mattiuzzi C. et al. Updates on larynx cancer epidemiology. Chin J Cancer Res 2020; 32: 18-25
• 172 Lopez F, Williams MD, Cardesa A. et al. How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?. Eur Arch Oto-Rhino-L 2017; 274: 2709-2726
• 173 Lovato A, Staffieri A, Marino F. et al. Immunohistochemical and HPV-related features of laryngeal adenosquamous carcinoma. Am J Otolaryng 2015; 36: 442-445
• 174 Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J 2006; 85: 74
• 175 Dubal PM, Unsal AA, Echanique KA. et al. Laryngeal adenosquamous carcinoma: A population-based perspective. Laryngoscope 2016; 126: 858-863
• 176 Keelawat S, Liu CZ, Roehm PC. et al. Adenosquamous carcinoma of the upper aerodigestive tract: a clinicopathologic study of 12 cases and review of the literature. Am J Otolaryngol 2002; 23: 160-168
• 177 Kusafuka K, Muramatsu K, Iida Y. et al. MUC expression in adenosquamous carcinoma of the head and neck regions of Japanese patients: immunohistochemical analysis. Pathol Int 2014; 64: 104-114
• 178 Yoshimura Y, Mishima K, Obara S. et al. Clinical characteristics of oral adenosquamous carcinoma: report of a case and an analysis of the reported Japanese cases. Oral Oncol 2003; 39: 309-315
• 179 Marioni G, Mariuzzi L, Gaio E. et al. Lymphoepithelial carcinoma of the larynx. Acta Oto-Laryngol 2002; 122: 429-434
• 180 Kermani W, Belcadhi M, Sriha B. et al. Epstein-Barr virus-associated lymphoepithelial carcinoma of the larynx. Eur Ann Otorhinolary 2015; 132: 231-233
• 181 Andryk J, Freije JE, Schultz CJ. et al. Lymphoepithelioma of the larynx. Am J Otolaryng 1996; 17: 61-63
• 182 MacMillan C, Kapadia SB, Finkelstein SD. et al. Lymphoepithelial carcinoma of the larynx and hypopharynx: Study of eight cases with relationship to Epstein-Barr virus and p53 gene alterations, and review of the literature. Hum Pathol 1996; 27: 1172-1179
• 183 Coskun BU, Cinar U, Sener BM. et al. Lymphoepithelial carcinoma of the larynx. Auris Nasus Larynx 2005; 32: 189-193
• 184 Sone M, Nakashima T, Nagasaka T. et al. Lymphoepithelioma-like carcinoma of the larynx associated with an Epstein-Barr viral infection. Otolaryng Head Neck 1998; 119: 134-137
• 185 Iezzoni JC, Gaffey MJ, Weiss LM. The Role of Epstein-Barr-Virus in Lymphoepithelioma-Like Carcinomas. American Journal of Clinical Pathology 1995; 103: 308-315
• 186 Coskun BU, Cinar U, Sener BM. et al. Lymphoepithelial carcinoma of the larynx. Auris Nasus Larynx 2005; 32: 189-193
• 187 Marioni G, Mariuzzi L, Gaio E. et al. Lymphoepithelial carcinoma of the larynx. Acta Otolaryngol 2002; 122: 429-434
• 188 Ibrahimov M, Yilmaz M, Celal MH. et al. Lymphoepithelial carcinoma of the larynx. J Craniofac Surg 2013; 24: 1049
• 189 Ferlito A, Weiss LM, Rinaldo A. et al. Clinicopathological consultation. Lymphoepithelial carcinoma of the larynx hypopharynx, and trachea. Ann Otol Rhinol Laryngol 1997; 106: 437-444
• 190 Testa D, Guerra G, Conzo G. et al. Glottic-Subglottic adenoid cystic carcinoma. A case report and review of the literature. BMC Surg 2013; 13: S48
• 191 Jones AV, Craig GT, Speight PM. et al. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol 2008; 44: 407-417
• 192 Dubal PM, Svider PF, Folbe AJ. et al. Laryngeal adenoid cystic carcinoma: A population-based perspective. Laryngoscope 2015; 125: 2485-2490
• 193 Batsakis JG, Luna MA, el-Naggar AK. Nonsquamous carcinomas of the larynx. Ann Otol Rhinol Laryngol 1992; 101: 1024-1026
• 194 Ganly I, Patel SG, Coleman M. et al. Malignant minor salivary gland tumors of the larynx. Arch Otolaryngol Head Neck Surg 2006; 132: 767-770
• 195 Del Negro A, Ichihara E, Tincani AJ. et al. Laryngeal adenoid cystic carcinoma: case report. Sao Paulo Med J 2007; 125: 295-296
• 196 Idowu MO, Reiter ER, Powers CN. Adenoid cystic carcinoma: a pitfall in aspiration cytology of the thyroid. Am J Clin Pathol 2004; 121: 551-556
• 197 Brill LB, Kanner WA, Fehr A. et al. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol 2011; 24: 1169-1176
• 198 Saraydaroglu O, Coskun H, Kasap M. Unique presentation of adenoid cystic carcinoma in postcricoid region: a case report and review of the literature. Head Neck Pathol 2011; 5: 413-415
• 199 Liu W, Chen X. Adenoid cystic carcinoma of the larynx: a report of six cases with review of the literature. Acta Otolaryngol 2015; 135: 489-493
• 200 Avery CM, Moody AB, McKinna FE. et al. Combined treatment of adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg 2000; 29: 277-279
• 201 Fordice J, Kershaw C, El-Naggar A. et al. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999; 125: 149-152
• 202 Garden AS, Weber RS, Morrison WH. et al. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 1995; 32: 619-626
• 203 Chen AM, Bucci MK, Weinberg V. et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys 2006; 66: 152-159
• 204 Lang K, Baur M, Akbaba S. et al. Intensity Modulated Radiotherapy (IMRT)+Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity. Cancers (Basel) 2018; 10
• 205 Kokemueller H, Eckardt A, Brachvogel P. et al. Adenoid cystic carcinoma of the head and neck--a 20 years experience. Int J Oral Maxillofac Surg 2004; 33: 25-31
• 206 Alavi S, Namazie A, Calcaterra TC. et al. Glandular carcinoma of the larynx: the UCLA experience. Ann Otol Rhinol Laryngol 1999; 108: 485-489
• 207 Mahlstedt K, Ussmuller J, Donath K. Malignant sialogenic tumours of the larynx. J Laryngol Otol 2002; 116: 119-122
• 208 Cohen J, Guillamondegui OM, Batsakis JG. et al. Cancer of the Minor Salivary-Glands of the Larynx. Am J Surg 1985; 150: 513-518
• 209 Prgomet D, Bilic M, Bumber Z. et al. Mucoepidermoid carcinoma of the larynx: report of three cases. Journal of Laryngology and Otology 2003; 117: 998-1000
• 210 Bhagat S, Varshney S, Singh RK. et al. Mucoepidermoid carcinoma of the larynx with transglottic involvement in a child: A case report. Ent-Ear Nose Throat 2012; 91: 533-535
• 211 Kleinsasser O. Tumors of the larynx and hypopharynx. Thieme Publishing Group; 1988
• 212 Ferlito A, Recher G, Bottin R. Mucoepidermoid Carcinoma of the Larynx – a Clinicopathological Study of 11 Cases with Review of the Literature. Orl J Oto-Rhino-Lary 1981; 43: 280-299
• 213 King W, Ko S, Miller D. Recurrent High-Grade Invasive Mucoepidermoid Carcinoma of Larynx: A Case Report and Review of the Literature. Rare Tumors 2016; 8: 6204
• 214 Gale N, Poljak M, Zidar N. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space. Head Neck Pathol 2017; 11: 23-32
• 215 van der Laan TP, Plaat BE, van der Laan BF. et al. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases. Head Neck 2015; 37: 707-715
• 216 Ferlito A, Rinaldo A, Bishop JA. et al. Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance. Eur Arch Otorhinolaryngol 2016; 273: 533-536
• 217 Chung JH, Lee SS, Shim YS. et al. A study of moderately differentiated neuroendocrine carcinomas of the larynx and an examination of non-neoplastic larynx tissue for neuroendocrine cells. Laryngoscope 2004; 114: 1264-1270
• 218 Feola T, Puliani G, Sesti F. et al. Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature. Front Endocrinol (Lausanne) 2020; 11: 397
• 219 Machens A, Holzhausen HJ, Dralle H. Minimally invasive surgery for recurrent neuroendocrine carcinoma of the supraglottic larynx. Eur Arch Otorhinolaryngol 1999; 256: 242-246
• 220 Jadhav S, Basu S. Metastatic large cell neuroendocrine carcinoma of larynx: Individualizing tumor biology by dual tracer positron emission tomography/computed tomography ((68)Ga-DOTATATE and (18)F-fluorodeoxyglucose) molecular imaging and disease stabilization following (177)Lu-DOTATATE peptide receptor radionuclide therapy after initial progression on chemoradiotherapy. World J Nucl Med 2019; 18: 431-433
• 221 Ferlito A, Silver CE, Bradford CR. et al. Neuroendocrine neoplasms of the larynx: an overview. Head Neck 2009; 31: 1634-1646
• 222 Kraus DH, Dubner S, Harrison LB. et al. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer 1994; 74: 697-702
• 223 Le Vay J, O’Sullivan B, Catton C. et al. An assessment of prognostic factors in soft-tissue sarcoma of the head and neck. Arch Otolaryngol Head Neck Surg 1994; 120: 981-986
• 224 Pellitteri PK, Ferlito A, Bradley PJ. et al. Management of sarcomas of the head and neck in adults. Oral Oncol 2003; 39: 2-12
• 225 Dubal PM, Svider PF, Kanumuri VV. et al. Laryngeal chondrosarcoma: a population-based analysis. Laryngoscope 2014; 124: 1877-1881
• 226 Oliveira JF, Branquinho FA, Monteiro AR. et al. Laryngeal chondrosarcoma--ten years of experience. Braz J Otorhinolaryngol 2014; 80: 354-358
• 227 Buda I, Hod R, Feinmesser R. et al. Chondrosarcoma of the larynx. Isr Med Assoc J 2012; 14: 681-684
• 228 Merrot O, Gleizal A, Poupart M. et al. Cartilaginous tumors of the larynx: endoscopic laser management using YAG/KTP. Head Neck 2009; 31: 145-152
• 229 Damiani V, Crosetti E, Rizzotto G. et al. Well and intermediate differentiated laryngeal chondrosarcoma: toward conservative surgery?. Eur Arch Otorhinolaryngol 2014; 271: 337-344
• 230 Gripp S, Pape H, Schmitt G. Chondrosarcoma of the larynx: the role of radiotherapy revisited--a case report and review of the literature. Cancer 1998; 82: 108-115
• 231 Hicks J, Flaitz C. Rhabdomyosarcoma of the head and neck in children. Oral Oncol 2002; 38: 450-459
• 232 Qualman SJ, Coffin CM, Newton WA. et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1998; 1: 550-561
• 233 Biegel JA, Nycum LM, Valentine V. et al. Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization. Genes Chromosomes Cancer 1995; 12: 186-192
• 234 Maheshwari GK, Baboo HA, Gopal U. et al. Primary rhabdomyosarcoma of the larynx. Indian J Otolaryngol Head Neck Surg 2004; 56: 138-141
• 235 Reiter R, Brosch S, Smith E. et al. Manifestation of Rheumatic Diseases in the Larynx. Laryngo Rhino Otol 2015; 94: 189-195
• 236 Speyer R, Speyer I, Heijnen MAM. Prevalence and relative risk of dysphonia in rheumatoid arthritis. Journal of Voice 2008; 22: 232-237
• 237 Fisher BA, Dolan K, Hastings L. et al. Prevalence of subjective voice impairment in rheumatoid arthritis. Clin Rheumatol 2008; 27: 1441-1443
• 238 Roy N, Tanner K, Merrill RM. et al. Descriptive Epidemiology of Voice Disorders in Rheumatoid Arthritis: Prevalence, Risk Factors, and Quality of Life Burden. J Voice 2016; 30: 74-87
• 239 Pradhan P, Bhardwaj A, Venkatachalam VP. Bilateral Cricoarytenoid Arthritis: A Cause of Recurrent Upper Airway Obstruction in Rheumatoid Arthritis. Malays J Med Sci 2016; 23: 89-91
• 240 Murano E, Hosako-Naito Y, Tayama N. et al. Bamboo node: Primary vocal fold lesion as evidence of autoimmune disease. Journal of Voice 2001; 15: 441-450
• 241 Beirith SC, Ikino CMY, Pereira IA. Laryngeal involvement in rheumatoid arthritis. Braz J Otorhinolar 2013; 79: 233-238
• 242 Loukili NH, Pettorin C, Noel E. et al. Type 1 autoimmune hepatitis revealed by a dysphonia related to cricoarytenoid arthritis. QJM 2003; 96: 171-172
• 243 Seve P, Poupart M, Bui-Xuan C. et al. Cricoarytenoid arthritis in Sjogren’s syndrome. Rheumatology International 2005; 25: 301-302
• 244 Nanke Y, Kotake S, Yonemoto K. et al. Cricoarytenoid arthritis with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2001; 28: 624-626
• 245 Habib MA. Intra-articular steroid injection in acute rheumatoid arthritis of the larynx. J Laryngol Otol 1977; 91: 909-910
• 246 Kerstens PJ, Boerbooms AM, Jeurissen ME. et al. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases. J Rheumatol 1992; 19: 867-871
• 247 Lanks CW, Van Natta TL, Hsia DW. Primary Laryngotracheal Amyloidosis With Bilateral Vocal Cord Involvement and Associated Bronchiectasis. J Bronchology Interv Pulmonol 2016; 23: 347-349
• 248 Ma L, Bandarchi B, Sasaki C. et al. Primary localized laryngeal amyloidosis: report of 3 cases with long-term follow-up and review of the literature. Arch Pathol Lab Med 2005; 129: 215-218
• 249 Ding L, Li W, Wang K. et al. Primary tracheobronchial amyloidosis in China: analysis of 64 cases and a review of literature. J Huazhong Univ Sci Technolog Med Sci 2010; 30: 599-603
• 250 Yakupova EI, Bobyleva LG, Vikhlyantsev IM. et al. Congo Red and amyloids: history and relationship. Bioscience Rep 2019; 39
• 251 Piazza C, Cavaliere S, Foccoli P. et al. Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients. Eur Arch Oto-Rhino-L 2003; 260: 349-354
• 252 Monroe AT, Walia R, Zlotecki RA. et al. Tracheobronchial amyloidosis: a case report of successful treatment with external beam radiation therapy. Chest 2004; 125: 784-789
• 253 Salato VK, Hacker-Foegen MK, Lazarova Z. et al. Role of intramolecular epitope spreading in pemphigus vulgaris. Clin Immunol 2005; 116: 54-64
• 254 Mahoney MG, Wang Z, Rothenberger K. et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999; 103: 461-468
• 255 Komai A, Amagai M, Ishii K. et al. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay. Brit J Dermatol 2001; 144: 1177-1182
• 256 Schmidt E, Goebeler M, Zillikens D. Rituximab in Severe Pemphigus. Ann Ny Acad Sci 2009; 1173: 683-691
• 257 Lee J, Lundgren DK, Mao X. et al. Antigen-specific B-cell depletion for precision therapy of mucosal pemphigus vulgaris. J Clin Invest. 2020
• 258 Ellebrecht CT, Bhoj VG, Nace A. et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 2016; 353: 179-184
• 259 Wojciechowska J, Krajewski W, Krajewski P. et al. Granulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current Knowledge. Clin Exp Otorhinolar 2016; 9: 8-13
• 260 Alam DS, Seth R, Sindwani R. et al. Upper airway manifestations of granulomatosis with polyangiitis. Cleve Clin J Med 2012; 79: S16-S21
• 261 Belloso A, Estrach C, Keith AO. Supraglottic stenosis in localized Wegener granulomatosis. Ear Nose Throat J 2008; 87: E11-E14
• 262 Radic M, Kaliterna DM, Radic J. Drug-induced vasculitis: a clinical and pathological review. Neth J Med 2012; 70: 12-17
• 263 Leavitt RY, Fauci AS, Bloch DA. et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 1990; 33: 1101-1107
• 264 Holle JU, Gross WL, Holl-Ulrich K. et al. Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: does it occur as persistent disease stage?. Ann Rheum Dis 2010; 69: 1934-1939
• 265 Trimarchi M, Sinico RA, Teggi R. et al. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmunity Reviews 2013; 12: 501-505
• 266 Smith E, Reiter R, Lindemann J. et al. Dysphonia as a Symptom of Sarcoidosis. Laryngo Rhino Otol 2014; 93: 115-116
• 267 Wu TJ, Lewis SM, Woo P. Neurosarcoidosis Presenting Initially as Idiopathic Vocal Cord Paralysis. Ann Oto Rhinol Laryn 2019; 128: 157-161
• 268 Strychowsky JE, Vargas SO, Cohen E. et al. Laryngeal sarcoidosis: Presentation and management in the pediatric population. Int J Pediatr Otorhi 2015; 79: 1382-1387
• 269 Morgenthau AS, Teirstein AS. Sarcoidosis of the upper and lower airways. Expert Rev Resp Med 2011; 5: 823-833
• 270 Edriss H, Kelley JS, Demke J. et al. Sinonasal and Laryngeal Sarcoidosis-An Uncommon Presentation and Management Challenge. Am J Med Sci 2019; 357: 93-102
• 271 Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med 1960; 263: 51-58
• 272 Mathew SD, Battafarano DF, Morris MJ. Relapsing polychondritis in the Department of Defense population and review of the literature. Semin Arthritis Rheum 2012; 42: 70-83
• 273 Buscatti IM, Giacomin MFA, Silva MFC. et al. Laryngotracheal stenosis requiring emergency tracheostomy as the first manifestation of childhood-relapsing polychondritis. Acta Reumatol Port 2013; 38: 208-211
• 274 McAdam LP, O’Hanlan MA, Bluestone R. et al. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976; 55: 193-215
• 275 Rafeq S, Trentham D, Ernst A. Pulmonary manifestations of relapsing polychondritis. Clin Chest Med 2010; 31: 513-518
• 276 Lang B, Rothenfusser A, Lanchbury JS. et al. Susceptibility to Relapsing Polychondritis Is Associated with Hla-Dr4. Arthritis Rheum 1993; 36: 660-664
• 277 Zeuner M, Straub RH, Rauh G. et al. Relapsing polychondritis: Clinical and immunogenetic analysis of 62 patients. Journal of Rheumatology 1997; 24: 96-101
• 278 Foidart JM, Martin GR, Abe S. et al. Antibodies to Type-2 Collagen and Circulating Immune-Complexes in Relapsing Polychondritis. Clin Res 1978; 26: A376-A376
• 279 Hansson AS, Heinegard D, Piette JC. et al. The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis Rheum 2001; 44: 2402-2412
• 280 Stabler T, Piette JC, Chevalier X. et al. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 2004; 50: 3663-3667
• 281 Paulsson M, Heinegard D. Radioimmunoassay of the 148-Kilodalton Cartilage Protein – Distribution of the Protein among Bovine-Tissues. Biochem J 1982; 207: 207-213
• 282 Spraggs PDR, Tostevin PMJ, Howard DJ. Management of laryngotracheobronchial sequelae and complications of relapsing polychondritis. Laryngoscope 1997; 107: 936-941
• 283 Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998; 129: 114-122
• 284 Dion J, Costedoat-Chalumeau N, Sene D. et al. Relapsing Polychondritis Can Be Characterized by Three Different Clinical Phenotypes: Analysis of a Recent Series of 142 Patients. Arthritis Rheumatol 2016; 68: 2992-3001
• 285 Frikha F, Bahloul Z. [Destructive chronic arthritis revealing a relapsing polychondritis]. Pan Afr Med J 2014; 17: 59
• 286 Damiani JM, Levine HL. Relapsing polychondritis--report of ten cases. Laryngoscope 1979; 89: 929-946
• 287 Michet CJ, McKenna CH, Luthra HS. et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986; 104: 74-78
• 288 Luthra HS, McKenna CH, Terasaki PI. Lack of association of HLA-A and B locus antigens with relapsing polychondritis. Tissue Antigens 1981; 17: 442-443
• 289 Shimizu J, Oka H, Yamano Y. et al. Cutaneous manifestations of patients with relapsing polychondritis: an association with extracutaneous complications. Clin Rheumatol 2016; 35: 781-783
• 290 Greco A, Gallo A, Fusconi M. et al. Cogan’s syndrome: an autoimmune inner ear disease. Autoimmun Rev 2013; 12: 396-400
• 291 Greco A, Gallo A, Fusconi M. et al. Bell’s palsy and autoimmunity. Autoimmun Rev 2012; 12: 323-328
• 292 Kent PD, Michet CJ, Luthra HS. Relapsing polychondritis. Curr Opin Rheumatol 2004; 16: 56-61
• 293 Hennessey JV. Riedel’s Thyroiditis: A Clinical Review. J Clin Endocr Metab 2011; 96: 3031-3041
• 294 Fatourechi MM, Hay ID, McIver B. et al. Invasive Fibrous Thyroiditis (Riedel Thyroiditis): The Mayo Clinic Experience, 1976-2008. Thyroid 2011; 21: 765-772
• 295 Ozgen A, Cila A. Riedel’s thyroiditis in multifocal fibrosclerosis: CT and MR imaging findings. Am J Neuroradiol 2000; 21: 320-321
• 296 Papi G, LiVolsi VA. Current concepts on Riedel thyroiditis. Am J Clin Pathol 2004; 121: S50-S63
• 297 Remerand G, Boespflug-Tanguy O, Tonduti D. et al. Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations. Dev Med Child Neurol 2019; 61: 1439-1447
• 298 Dumitrescu AM, Liao XH, Best TB. et al. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004; 74: 168-175
• 299 Pennock GD, Raya TE, Bahl JJ. et al. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity. J Pharmacol Exp Ther 1992; 263: 163-169
• 300 Moreno M, de Lange P, Lombardi A. et al. Metabolic effects of thyroid hormone derivatives. Thyroid 2008; 18: 239-253
• 301 Hartley MD, Kirkemo LL, Banerji T. et al. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy. Endocrinology 2017; 158: 1328-1338
• 302 Kersseboom S, Horn S, Visser WE. et al. In Vitro and Mouse Studies Supporting Therapeutic Utility of Triiodothyroacetic Acid in MCT8 Deficiency. Mol Endocrinol 2014; 28: 1961-1970
• 303 Braun D, Schweizer U. Efficient Activation of Pathogenic DeltaPhe501 Mutation in Monocarboxylate Transporter 8 by Chemical and Pharmacological Chaperones. Endocrinology 2015; 156: 4720-4730
• 304 Braun D, Schweizer U. The Chemical Chaperone Phenylbutyrate Rescues MCT8 Mutations Associated With Milder Phenotypes in Patients With Allan-Herndon-Dudley Syndrome. Endocrinology 2017; 158: 678-691
• 305 Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis 2010; 5
• 306 Harris KB, Pass KA. Increase in congenital hypothyroidism in New York State and in the United States (vol 91, pg 268, 2007). Mol Genet Metab 2008; 94: 140-140
• 307 Zhan JY, Qin YF, Zhao ZY. Neonatal screening for congenital hypothyroidism and phenylketonuria in China. World J Pediatr 2009; 5: 136-139
• 308 Lania A, Persani L, Beck-Peccoz P. Central hypothyroidism. Pituitary 2008; 11: 181-186
• 309 Wells SA, Asa SL, Dralle H. et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015; 25: 567-610
• 310 Pacini F, Castagna MG, Brilli L. et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23: vii110-vii119
• 311 Carlson KM, Dou S, Chi D. et al. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A 1994; 91: 1579-1583
• 312 Mulligan LM, Kwok JB, Healey CS. et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460
• 313 Thomas CM, Asa SL, Ezzat S. et al. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines. Curr Oncol 2019; 26: 338-344
• 314 Perros P, Boelaert K, Colley S. et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 2014; 81: 1-122
• 315 Tuttle RM, Ball DW, Byrd D. et al. Medullary carcinoma. J Natl Compr Canc Netw 2010; 8: 512-530
• 316 Costante G, Meringolo D, Durante C. et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007; 92: 450-455
• 317 Biesinger E, Bootz F, Weber B. Life saving glance diagnosis in type IIb multiple endocrine neoplasia. Laryngorhinootologie 1992; 71: 50-52
• 318 Wells SA, Gosnell JE, Gagel RF. et al. Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Oncol 2010; 28: 767-772
• 319 Tsang VH, Robinson BG, Learoyd DL. The safety of vandetanib for the treatment of thyroid cancer. Expert Opin Drug Saf 2016; 15: 1107-1113
• 320 Robinson BG, Paz-Ares L, Krebs A. et al. Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Endocrinol Metab 2010; 95: 2664-2671
• 321 Elisei R, Schlumberger MJ, Muller SP. et al. Cabozantinib in progressive medullary thyroid cancer. J Clin Oncol 2013; 31: 3639-3646
• 322 Sherman SI, Cohen EEW, Schoffski P. et al. Efficacy of cabozantinib (Cabo) in medullary thyroid cancer (MTC) patients with RAS or RET mutations: Results from a phase III study. Journal of Clinical Oncology 2013; 31
• 323 Larouche V, Akirov A, Thomas CM. et al. A primer on the genetics of medullary thyroid cancer. Curr Oncol 2019; 26: 389-394